CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
Haruhiko Ogata, Nobuo Aoyama, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi
Intest Res. 2017;15(3):368-379.   Published online June 12, 2017
DOI: https://doi.org/10.5217/ir.2017.15.3.368

Excel Download

Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
Intestinal Research. 2017;15(3):368   Crossref logo
Link1 Link2 Link3

Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study
Intestinal Research. 2018;16(2):255   Crossref logo
Link1 Link2 Link3

Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study
Intestinal Research. 2017;15(3):358   Crossref logo
Link1 Link2 Link3

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
Yearbook of Gastroenterology. 2009;2009:102-103   Crossref logo
Link1 Link2

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
Intestinal Research. 2018;16(2):163   Crossref logo
Link1 Link2 Link3

Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis
Clinical and Experimental Gastroenterology. 2014;369   Crossref logo
Link1

Mesalazine (5-ASA) micropellets show comparable efficacy and tolerability as mesalazine tablets in patients with ulcerative colitis a prospective, multinational, randomised, double-blind, active-controlled clinical phase II study
Gastroenterology. 2003;124(4):A379   Crossref logo
Link1 Link2

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis
Alimentary Pharmacology & Therapeutics. 2010;32(3):368-376   Crossref logo
Link1

Is topical therapy necessary in acute distal colitis? Double-blind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis
Alimentary Pharmacology & Therapeutics. 2007;5(5):513-522   Crossref logo
Link1

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial
Alimentary Pharmacology and Therapeutics. 2006;23(10):1403-1413   Crossref logo
Link1